Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscle-invasive bladder cancer? The jury is still out but the answer is likely no

  • Guan Hee Tan Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, ON, Canada.
  • Cynthia Kuk Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, ON, Canada
  • Alexandre R. Zlotta Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, ON, Canada
Keywords: bladder cancer, BCG, Bacillus Calmette-Guérin, non-muscle invasive bladder cancer, NMIBC, immunotherapy
Published
2019-07-23
How to Cite
Tan, G. H., Kuk, C., & Zlotta, A. R. (2019). Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscle-invasive bladder cancer? The jury is still out but the answer is likely no. Canadian Urological Association Journal, 14(2), E54-6. https://doi.org/10.5489/cuaj.5923
Section
Research Letter